rs12144567

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_014704.4(CEP104):​c.1884G>T​(p.Thr628Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0063 in 1,614,140 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T628T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0043 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0065 ( 44 hom. )

Consequence

CEP104
NM_014704.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -2.29
Variant links:
Genes affected
CEP104 (HGNC:24866): (centrosomal protein 104) This gene encodes a centrosomal protein required for ciliogenesis and for ciliary tip structural integrity. The mammalian protein contains three amino-terminal hydrophobic domains, two glycosylation sites, four cysteine-rich motifs, and two regions with homology to the glutamate receptor ionotropic, NMDA 1 protein. During ciliogenesis, the encoded protein translocates from the distal tips of the centrioles to the tip of the elongating cilium. Knockdown of the protein in human retinal pigment cells results in severe defects in ciliogenesis with structural deformities at the ciliary tips. Allelic variants of this gene are associated with the autosomal-recessive disorder Joubert syndrome, which is characterized by a distinctive mid-hindbrain and cerebellar malformation, oculomotor apraxia, irregular breathing, developmental delay, and ataxia. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 1-3829950-C-A is Benign according to our data. Variant chr1-3829950-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 542194.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.29 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0043 (655/152274) while in subpopulation AMR AF = 0.00745 (114/15296). AF 95% confidence interval is 0.00634. There are 3 homozygotes in GnomAd4. There are 318 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP104NM_014704.4 linkc.1884G>T p.Thr628Thr synonymous_variant Exon 14 of 22 ENST00000378230.8 NP_055519.1 O60308-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP104ENST00000378230.8 linkc.1884G>T p.Thr628Thr synonymous_variant Exon 14 of 22 5 NM_014704.4 ENSP00000367476.3 O60308-1

Frequencies

GnomAD3 genomes
AF:
0.00430
AC:
655
AN:
152156
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00109
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00746
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00359
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00644
Gnomad OTH
AF:
0.00815
GnomAD2 exomes
AF:
0.00440
AC:
1106
AN:
251478
AF XY:
0.00441
show subpopulations
Gnomad AFR exome
AF:
0.000984
Gnomad AMR exome
AF:
0.00697
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00212
Gnomad NFE exome
AF:
0.00658
Gnomad OTH exome
AF:
0.00847
GnomAD4 exome
AF:
0.00651
AC:
9520
AN:
1461866
Hom.:
44
Cov.:
33
AF XY:
0.00627
AC XY:
4559
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.00125
AC:
42
AN:
33480
Gnomad4 AMR exome
AF:
0.00660
AC:
295
AN:
44724
Gnomad4 ASJ exome
AF:
0.000268
AC:
7
AN:
26136
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39700
Gnomad4 SAS exome
AF:
0.0000580
AC:
5
AN:
86252
Gnomad4 FIN exome
AF:
0.00200
AC:
107
AN:
53420
Gnomad4 NFE exome
AF:
0.00780
AC:
8679
AN:
1111990
Gnomad4 Remaining exome
AF:
0.00614
AC:
371
AN:
60396
Heterozygous variant carriers
0
485
969
1454
1938
2423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
320
640
960
1280
1600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00430
AC:
655
AN:
152274
Hom.:
3
Cov.:
33
AF XY:
0.00427
AC XY:
318
AN XY:
74442
show subpopulations
Gnomad4 AFR
AF:
0.00108
AC:
0.00108262
AN:
0.00108262
Gnomad4 AMR
AF:
0.00745
AC:
0.00745293
AN:
0.00745293
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.000207
AC:
0.000207297
AN:
0.000207297
Gnomad4 FIN
AF:
0.00359
AC:
0.00358761
AN:
0.00358761
Gnomad4 NFE
AF:
0.00644
AC:
0.00643853
AN:
0.00643853
Gnomad4 OTH
AF:
0.00806
AC:
0.00806452
AN:
0.00806452
Heterozygous variant carriers
0
35
70
106
141
176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00374
Hom.:
1
Bravo
AF:
0.00442
EpiCase
AF:
0.00616
EpiControl
AF:
0.00729

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CEP104: BP4, BP7, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 28, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Joubert syndrome 25 Benign:1
Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CEP104-related disorder Benign:1
Jul 15, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.17
DANN
Benign
0.47
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12144567; hg19: chr1-3746514; COSMIC: COSV100986756; COSMIC: COSV100986756; API